FB Pixel no scriptDeep Tech | KrASIA
MENU
KrASIA

Deep Tech

News

Innogen bets on longer-lasting GLP-1 drugs to stand out in crowded field

The company hopes to stand out with Diabegone, a diabetes treatment that lasts longer than competing drugs from companies like Novo Nordisk and Eli Lilly.

4 mins read
  • Fears of more US restrictions are pushing companies to develop in-house solutions.

    Insights

    China’s automakers speed up efforts to replace Nvidia chips

    6 mins read

Most Recent

See All